1000-2000 5 ьшò
.pdf
– Penetrating ocular trauma, gonococcal conjunctivitis
ONGOING CARE
FOLLOW-UPRECOMMENDATIONS
If not resolved within 5 to 7 days, alternate diagnoses should be considered or consultation obtained, although some epidemic keratoconjunctivitis and other adenoviral conjunctivitis typically last 1 to 2 weeks.
Children may be excluded from school until eye is no longer red, if viral or bacterial, depending on school policy. Allergic conjunctivitis should be able to return to school with doctor’s note.
PATIENT EDUCATION
Patients should not wear contacts until their eyes are fully healed (typically 1 week).
Patients should discard current contacts.
Patients should discard eye makeup they had been using, especially mascara.
Cool, moist compress can ease irritation and itch.
PROGNOSIS
Viral: 5 to 10 days of symptoms for pharyngitis with conjunctivitis, 2 weeks with adenovirus
Herpes simplex: 2 to 3 weeks of symptoms
Most common bacterial—H. influenzae, Staphylococcus, Streptococcus: self– limited; 74–80% resolution within 7 days, whether treated or not
COMPLICATIONS
Corneal scars with herpes simplex
Lid scars or entropion with varicella zoster and chlamydia
Corneal ulcers or perforation, very rapid with gonococcal
Hypopyon: pus in anterior chamber
Chlamydial neonatal (ophthalmic): could have concomitant pneumonia
Otitis media may follow H. influenzae conjunctivitis.
Very rarely N. meningitidis conjunctivitis may be followed by meningitis.
REFERENCES
mebooksfree.com
1.Steeples L, Mercieca K. Acute conjunctivitis in primary care: antibiotics and placebo associated with small increase in the proportion cured by 7 days compared with no treatment. Evid Based Med. 2012;17(6):177–178.
2.Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2015; (1):CD002898.
3.Castillo M, Scott NW, Mustafa MZ, et al. Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis.
Cochrane Database Syst Rev. 2015;(6):CD009566.
4.Herretes S, Wang X, Reyes JM. Topical corticosteroids as adjunctive therapy for bacterial keratitis. Cochrane Database Syst Rev. 2014;(10):CD005430.
5.Mammas IN, Theodoridou M, Kramvis A, et al. Paediatric virology: a rapidly increasing educational challenge. Exp Ther Med. 2017;13(2):364–377.
ADDITIONALREADING
Berger WE, Granet DB, Kabat AG. Diagnosis and management of allergic conjunctivitis in pediatric patients. Allergy Asthma Proc. 2017;38(1):16–27.
SEE ALSO
Rhinitis, Allergic
Algorithm: Eye Pain
CODES
ICD10
H10.30 Unspecified acute conjunctivitis, unspecified eye
H10.33 Unspecified acute conjunctivitis, bilateral
H10.32 Unspecified acute conjunctivitis, left eye
CLINICALPEARLS
Conjunctivitis does not alter visual acuity; decreased acuity or photophobia should prompt consideration of more serious ophthalmic disorders.
Culture the discharge in all contact lens wearers, consider referral, and remind patient to throw away current contacts and avoid contacts until eyes are fully
mebooksfree.com
healed.
Antibiotics are of no value in viral conjunctivitis (most cases of infectious conjunctivitis) and do not significantly alter the course of most types of bacterial conjunctivitis.
Treating symptomatically for 3 days before prescribing an antibiotic is appropriate for adults and children >1 month.
mebooksfree.com
CONSTIPATION
S. Mimi Mukherjee, PharmD
Sandra Marwill, MD, MPH
BASICS
Unsatisfactory defecation characterized by infrequent stools, difficult stool passage, or both. Characteristics include <3 bowel movements a week, hard stools, excessive straining, prolonged time spent on the toilet, a sense of incomplete evacuation, and abdominal discomfort/bloating.
DESCRIPTION
System(s) affected: gastrointestinal (GI)
Synonym(s): obstipation
Geriatric Considerations
Colorectal neoplasms may be associated with constipation; new-onset constipation after age 50 years is a “red flag.” Use warm water enemas for impaction instead of sodium phosphate enema in geriatric patients. Sodium phosphate enemas have been associated with fatalities and severe electrolyte disturbances (1)[B].
Pediatric Considerations
Consider Hirschsprung disease (absence of colonic ganglion cells): 25% of all newborn intestinal obstructions, milder cases diagnosed in older children with chronic constipation, abdominal distension, decreased growth; 5:1 male-to- female ratio; associated with inherited conditions (e.g., Down syndrome)
Pregnancy Considerations
Avoid misoprostol. Always consider risks versus benefits when deciding on treatment.
EPIDEMIOLOGY
More pronounced in children and elderly
Predominant sex: female > male (2:1)
Nonwhites > whites
mebooksfree.com
Incidence
5 million office visits annually
100,000 hospitalizations
Prevalence
16% of adults >18 years, rising to 33% of adults >60 years of age
3% of physician visits in children relate to constipation.
ETIOLOGYAND PATHOPHYSIOLOGY
As food leaves the stomach, the ileocecal valve relaxes (gastroileal reflex) and chyme enters the colon (1 to 2 L/day) from the small intestine. In the colon, sodium is actively absorbed in exchange for potassium and bicarbonate. Water follows the osmotic gradient. Peristaltic contractions move chyme through the colon into the rectum. Chyme is converted into feces (200 to 250 mL).
Normal transit time is 4 hours to reach the cecum and 12 hours to reach the distal colon.
Defecation reflexively follows once stool reaches the rectal vault. This reflex can be inhibited by voluntarily contracting the external sphincter or facilitated by straining to contract the abdominal muscles while voluntarily relaxing the anal sphincter. Rectal distention initiates the defecation reflex. The urge to defecate occurs as rectal pressures increase. Distention of the stomach also initiates rectal contractions and a desire to defecate (gastrocolic reflex).
Primary and secondary defecation disorders result from delay in colonic transit, altered rectal motor activity, and structural or functional problems with pelvic floor muscles (including paradoxical contractions, diminished ability to relax sphincter, and/or poor propulsion).
Genetics
Unknown but may be familial
RISK FACTORS
Very young and very old
Polypharmacy
Sedentary lifestyle or condition
Improper diet and inadequate fluid intake
GENERALPREVENTION
High-fiber diet, adequate fluids, exercise, and training to “obey the urge” to
mebooksfree.com
defecate
COMMONLYASSOCIATED CONDITIONS
General debilitation (disease or aging)
Dehydration
Hypothyroidism
Hypokalemia
Hypercalcemia
Nursing home resident
DIAGNOSIS
ALERT
Red flags:
New onset after age of 50 years
Hematochezia/melena
Unintentional weight loss
Family history of colon cancer
Anemia
Neurologic defects
HISTORY
Assess onset of symptoms, number of bowel movements per week, straining, completeness of evacuation, use of manual manipulation.
Identify red flags; evaluate diet, lifestyle, prescription, and OTC medication use; identify reversible causes; ask about history of sexual abuse, illicit opioid use.
Bristol Stool Form Scale—seven categories of consistency (2)
Bowel and diet diary help to measure treatment response.
Rome III criteria (3)[C]:
–At least two of the following for 12 weeks in the previous 6 months:
<3 stools per week
Straining at least 1/4 of the time
Hard stools at least 1/4 of time
Need for manual assist at least 1/4 of time
Sense of incomplete evacuation at least 1/4 of time
Sense of anorectal blockade at least 1/4 of time
mebooksfree.com
–Loose stools rarely seen without use of laxatives
–Frequent constipation but does not meet irritable bowel syndrome (IBS) criteria
–Although there can be overlap, the history of primary constipation differs from constipation-predominant IBS.
In primary constipation, pain and bloating are relieved by adequate defecation. In IBS, pain and bloating predominate and are not readily relieved by defecation.
PHYSICALEXAM
Vital signs
Abdominal exam, previous surgical scars, hypoactive bowel sounds, tenderness and masses
Gynecologic exam: Evaluate for masses and rectocele.
Digital rectal exam: Evaluate for masses, pain, stool, fissures, hemorrhoids; assess sphincter tone.
Neurologic exam
DIFFERENTIALDIAGNOSIS
Primary constipation (primary problem is within the GI tract) four subtypes
–Normal colonic transit time most common subtype; can be difficult to differentiate from constipation-predominant IBS
–Slow colonic transit time
–Pelvic floor/anal sphincter dysfunction
–Combination pelvic floor/anal sphincter dysfunction and slow transit
Secondary constipation (outside the GI tract)
–Endocrine dysfunction (diabetes mellitus, hypothyroid)
–Metabolic disorder (increased calcium, decreased potassium)
–Mechanical (obstruction, rectocele)
–Pregnancy
–Neurologic disorders (Hirschsprung, multiple sclerosis, spinal cord injuries,
Parkinson disease)
Congenital
–Hirschsprung disease/syndrome
–Hypoganglionosis
–Congenital dilation of the colon
–Small left colon syndrome
Medication effect
– Anticholinergic effects (antidepressants, opioids antipsychotics)
mebooksfree.com
–Antacids (calcium, aluminum)
–Nondihydropyridine calcium channel blockers, especially verapamil
–Iron and multivitamins with iron
–Diuretics
–Overuse of antidiarrheal medications
DIAGNOSTIC TESTS & INTERPRETATION
Identify red flags, secondary causes, and reversible conditions. If none present, go to first-line treatment.
Initial Tests (lab, imaging)
CBC to screen for iron deficiency anemia
Consider tox screen if suspect illicit opioid use
Calcium, glucose, and thyroid function testing (TSH) based on history and exam. If red flags are present, refer for sigmoid/colonoscopy.
Follow-Up Tests & Special Considerations
For patients with pelvic floor dysfunction or exam abnormalities (e.g., rectocele) and/ or patients who are refractory to initial treatment, refer to an experienced subspecialist. An experienced biofeedback physical therapist can be very helpful.
Diagnostic Procedures/Other
Anorectal manometry (ARM)
Balloon expulsion testing (BET)
Scintigraphy
MRI
Defecography
Colonic marker studies
Test Interpretation
ARM and BET recommended for all refractory cases
If ARM and BET are negative, scintigraphy may help evaluate transit time. Some recommend biofeedback prior to scintigraphy.
TREATMENT
mebooksfree.com
Address immediate concerns:
Bloating/discomfort/straining: osmotic agents
Postoperative, after childbirth, hemorrhoids, fissures: stool softener to aid defecation
If impacted: manual disimpaction, then treat any underlying conditions.
GENERALMEASURES
In patients with no known secondary causes, conservative nonpharmacologic treatment is recommended.
Eliminate medications that cause constipation.
Increase fluid intake.
Increase soluble fiber in diet.
Encourage regular defecation attempts after eating.
Regular exercise
Enemas if other methods fail (avoid sodium phosphate enemas in geriatric patients)
MEDICATION
Nonprescription medications are first line. If patient goals are not reached, advance to prescription medications.
First Line
Bulking agents (accompanied by adequate fluids):
Hydrophilic colloids (bulk-forming agents)
–Psyllium (Konsyl, Metamucil, Perdiem Fiber): 1 tbsp in 8-oz liquid PO daily up to TID
–Methylcellulose (Citrucel): 1 tbsp in 8-oz liquid PO daily up to TID
–Polycarbophil (Mitrolan, FiberCon): 2 caplets with 8-oz liquid PO up to QID
Stool softeners
– Docusate sodium (Colace): 50 to 100 mg PO TID
Osmotic laxatives
–Polyethylene glycol (PEG) (MiraLax) 17 g/day PO dissolved in 4 to 8 oz of beverage (current evidence shows PEG to be superior to lactulose) (4)[B]
–Lactulose (Chronulac, Enulose) 15 to 60 mLPO QHS (flatulence, bloating, cramping)
–Sorbitol: 15 to 60 mLPO QHS (as effective as lactulose)
–Magnesium salts (milk of magnesia) 15 to 30 mLPO once daily; avoid in
mebooksfree.com
renal insufficiency.
Second Line
Stimulants (irritate bowel, causing muscle contraction; usually combined with a softener; work in 8 to 12 hours)
–Senna/docusate (Senokot-S, Ex-lax, Peri-Colace): 1 to 2 tablets or 15 to 30 mLPO at bedtime
–Bisacodyl (Dulcolax, Correctol): 1 to 3 tablets PO daily
Lubricants (soften stool and facilitate passage of the feces by its lubricating oily effects)
–Mineral oil (15 to 45 mL/day)
–Short-term use only; can bind fat-soluble vitamins, with the potential for deficiencies; may similarly decrease absorption of some drugs
–Avoid in those at risk for aspiration (lipoid pneumonia).
Suppositories
–Osmotic: sodium phosphate
–Lubricant: glycerin
–Stimulatory: bisacodyl
–Enemas: saline (Fleet enema)
Lubiprostone (Amitiza): a selective chloride channel activator; 24 µg PO BID
Guanylate cyclase-C agonists (adult use only)
–Linaclotide (Linzess): dose: 145 µg PO once daily;
–Plecanatide (Trulance): dose: 3 mg PO once daily
Peripherally acting µ-opioid receptor antagonists, indicated for opioid-induced constipation
–Methylnaltrexone (Relistor): dose: 38 to <62 kg: 8 mg; 62 to 114 kg: 12 mg SC every other day PRN
–Naloxegol (Movantik): dose: 12.5 to 25.0 mg PO daily; discontinue other laxatives for 3 days when initiating naloxegol; avoid in patients on strong Cyp3A4 inhibitors due to increased naloxegol levels and risk of opioid withdrawal.
–Naldemedine (Symproic): dose: 0.2 mg PO daily; monitor for opioid withdrawal in patients on strong Cyp3A4 inhibitors or P-gp inhibitors.
Prokinetic agents (partial 5-HT4 agonists) have been withdrawn due to cardiac side effects; only available via IND protocols: tegaserod (Zelnorm), cisapride (Propulsid)
Other agents not approved by the FDA:
–Misoprostol (Cytotec): a prostaglandin that increases colonic motility
–Colchicine: neurogenic stimulation to increase colonic motility
mebooksfree.com
